Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
Yazar
Cardoso, F.
Lin, C.
Gradishar, W.
Azevedo, S.
Ozguroglu, M.
Bachelot, T.
Royce, M.
Villanueva, C.
Melo Cruz, F.
Hegg, R.
Falkson, C.
Jeong, J.
Srimuninnimit, V.
Arce, C. H.
Ridolfi, A.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]